Zaremba Rabourn Amy 4

What Happened
Amy Zaremba, Head of Financial Quality Assurance at Opus Genetics (IRD), disposed of 2,816 shares on March 16, 2026 at $5.25 per share, for gross proceeds of $14,770. The Form 4 was filed March 18, 2026. This was a sale (not a purchase) and therefore is typically interpreted as a routine disposition rather than a bullish insider purchase.

Key Details

• Transaction date: 2026-03-16; filing date: 2026-03-18.
• Transaction: Sale of 2,816 shares at $5.25 per share; total proceeds $14,770.
• Method: Reported as open market or private sale (S).
• Footnote: The sale was automatic to satisfy tax withholding obligations arising from a vesting and settlement of restricted stock units (RSUs); it was not a discretionary trade by the reporting person (Footnote F1).
• Shares owned after transaction: Not specified in the provided filing summary.
• Timeliness: Filed two days after the transaction (within the typical Form 4 reporting window).

Context
Tax-withholding sales tied to RSU vesting are common and usually administrative (they do not necessarily reflect the insider’s market view). The dollar amount here ($14.8k) is relatively small compared with many executive trades and was executed to meet withholding requirements rather than as an investment decision.